We build lasting partnerships with European pharmaceutical and life-science companies, supporting the full journey from initial product screening and medical-value assessment through registration planning and market access. Over 80 products evaluated to date, with 40+ advanced to China market access planning.
Shuaizhijia Group
Each partnership moves through transparent milestones, respecting healthcare timelines while keeping commercialization executable.
01
Four specialist teams — medical, regulatory, supply chain and market — contribute structured assessments. Over 80 products systematically evaluated to date.
02
Based on product characteristics and competitive landscape, we build complete plans covering registration paths, access strategy, channel design, academic promotion and regional execution, with quantifiable stage-gate milestones.
03
Local teams across three major regions, a proven quality management system and a 120+ channel partner network drive ongoing operations, market feedback collection and strategy iteration.
